Evidence map›Paper›PMID 26266538›Full record

ArticlePloS one2015

c-Myc Alters Substrate Utilization and O-GlcNAc Protein Posttranslational Modifications without Altering Cardiac Function during Early Aortic Constriction.

Dolena Ledee, Lincoln Smith, Margaret Bruce, Masaki Kajimoto, Nancy Isern, Michael A Portman, Aaron K Olson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Role of STIM1 in the Regulation of Cardiac Energy Substrate Preference.International journal of molecular sciences · 2023
    Review
  10. Frontiers in endocrinology · 2023
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Role ofPhysiological reviews · 2021
    Review
  17. Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.Biochimica et biophysica acta. Molecular basis of disease · 2020
    Review
  18. Article
  19. Glucose Metabolism in Cardiac Hypertrophy and Heart Failure.Journal of the American Heart Association · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Dolena LedeeSeattle Children's Research Institute, Seattle, WA, United States of America.
Lincoln SmithDepartment of Pediatrics, Division of Critical Care Medicine, University of Washington, Seattle, Washington, United States of America.
Margaret BruceSeattle Children's Research Institute, Seattle, WA, United States of America.
Masaki KajimotoSeattle Children's Research Institute, Seattle, WA, United States of America.
Nancy IsernEnvironmental Molecular Sciences Laboratory (EMSL), Pacific Northwest National Laboratory, Richland, WA, United States of America.
Michael A PortmanSeattle Children's Research Institute, Seattle, WA, United States of America; Department of Pediatrics, Division of Cardiology, University of Washington, Seattle, Washington, United States of America.
Aaron K OlsonSeattle Children's Research Institute, Seattle, WA, United States of America; Department of Pediatrics, Division of Cardiology, University of Washington, Seattle, Washington, United States of America.
University of Washington · USPacific Northwest National Laboratory · US

Funding

CARDIOVASCULAR RESEARCH TRAINING PROGRAMT32HL007828 · NHLBI · UNIVERSITY OF WASHINGTON · PI Francis Kim, Farid Moussavi-Harami · 1997 to 2026
$10.2M
Metabolic regulation of O-GlcNAc and cardiac function during hypertrophyR01HL122546 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI OLSON, AARON K · 2015 to 2019
$2.7M
Metabolic Substrate Utilization During c-Myc Induced Cardiac HypertrophyK08HL092333 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI OLSON, AARON K · 2009 to 2013
$645k
NHLBI NIH HHS K08 HL092333NHLBI NIH HHS K08-HL-092333NHLBI NIH HHS R01 HL122546NHLBI NIH HHS T32 HL007828
6 · The paper itself

Abstract

Hypertrophic stimuli cause transcription of the proto-oncogene c-Myc (Myc). Prior work showed that myocardial knockout of c-Myc (Myc) attenuated hypertrophy and decreased expression of metabolic genes after aortic constriction. Accordingly, we assessed the interplay between Myc, substrate oxidation and cardiac function during early pressure overload hypertrophy. Mice with cardiac specific, inducible Myc knockout (MycKO-TAC) and non-transgenic littermates (Cont-TAC) were subjected to transverse aortic constriction (TAC; n = 7/group). Additional groups underwent sham surgery (Cont-Sham and MycKO-Sham, n = 5 per group). After two weeks, function was measured in isolated working hearts along with substrate fractional contributions to the citric acid cycle by using perfusate with 13C labeled mixed fatty acids, lactate, ketone bodies and unlabeled glucose and insulin. Cardiac function was similar between groups after TAC although +dP/dT and -dP/dT trended towards improvement in MycKO-TAC versus Cont-TAC. In sham hearts, Myc knockout did not affect cardiac function or substrate preferences for the citric acid cycle. However, Myc knockout altered fractional contributions during TAC. The unlabeled fractional contribution increased in MycKO-TAC versus Cont-TAC, whereas ketone and free fatty acid fractional contributions decreased. Additionally, protein posttranslational modifications by O-GlcNAc were significantly greater in Cont-TAC versus both Cont-Sham and MycKO-TAC. In conclusion, Myc alters substrate preferences for the citric acid cycle during early pressure overload hypertrophy without negatively affecting cardiac function. Myc also affects protein posttranslational modifications by O-GlcNAc during hypertrophy, which may regulate Myc-induced metabolic changes.

Indexed as

Protein Processing, Post-TranslationalAcetylationAcetylglucosamineAnimalsAortic Valve StenosisCardiomyopathy, HypertrophicCitric Acid CycleMiceProto-Oncogene Proteins c-mycAcetylglucosamineMyc protein, mouseProto-Oncogene Proteins c-myc

Identifiers

PMID26266538
PMCPMC4534195
OpenAlexW2158878058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.